Pfizer will request the authorization of the vaccine from the third week of November
Pfizer’s late-stage coronavirus vaccine trial is near complete. The countdown to the arrival of the…
Pfizer’s late-stage coronavirus vaccine trial is near complete. The countdown to the arrival of the…
Breathonix develops non-invasive breath tests for disease detection. Singapore’s Breathonix has said a clinical trial…
Moderna prepares for the “commercial launch” of its vaccine. Modern biotechnology begins the procedures to…
Grifols starts the trial to test its immunoglobulin in patients with Covid-19. Grifols has announced…
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells…
Merger between Sanofi and Principia Biopharma. The French pharmaceutical Sanofi has reached a “definitive agreement”…
CytoDyn rejected by the FDA. The FDA rejected CytoDyn’s application for its lead program, an…
Genetically modified mosquitoes for the field. A British biotech company has approval to release genetically…
Moderna lab, the small biotechnology that can save the world from COVID-19. Moderna is using…